Vitroscope Raises $7M for Living Tissue Tech

Trondheim-based biotech firm Vitroscope raised $7 million total to advance its living tissue technology. The round includes a $5 million seed investment from Cerberus Ventures and YZR Capital, plus $2 million in non-dilutive funding from the Research Council of Norway, bringing total capital to $8.8 million.